25 XP   0   0   10

BioGaia AB (publ)
Buy, Hold or Sell?

Let's analyse Biogaia together

PenkeI guess you are interested in BioGaia AB (publ). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioGaia AB (publ). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BioGaia AB (publ)

I send you an email if I find something interesting about BioGaia AB (publ).

Quick analysis of Biogaia (30 sec.)










What can you expect buying and holding a share of Biogaia? (30 sec.)

How much money do you get?

How much money do you get?
kr1.05
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
kr20.11
Expected worth in 1 year
kr22.40
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
kr13.89
Return On Investment
11.8%

For what price can you sell your share?

Current Price per Share
kr117.90
Expected price per share
kr109.40 - kr135.60
How sure are you?
50%

1. Valuation of Biogaia (5 min.)




Live pricePrice per Share (EOD)

kr117.90

Intrinsic Value Per Share

kr25.57 - kr50.63

Total Value Per Share

kr45.68 - kr70.74

2. Growth of Biogaia (5 min.)




Is Biogaia growing?

Current yearPrevious yearGrowGrow %
How rich?$184.3m$179m$5.2m2.9%

How much money is Biogaia making?

Current yearPrevious yearGrowGrow %
Making money$33.1m$33.9m-$764.6k-2.3%
Net Profit Margin28.2%33.9%--

How much money comes from the company's main activities?

3. Financial Health of Biogaia (5 min.)




What can you expect buying and holding a share of Biogaia? (5 min.)

Welcome investor! Biogaia's management wants to use your money to grow the business. In return you get a share of Biogaia.

What can you expect buying and holding a share of Biogaia?

First you should know what it really means to hold a share of Biogaia. And how you can make/lose money.

Speculation

The Price per Share of Biogaia is kr117.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biogaia.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biogaia, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr20.11. Based on the TTM, the Book Value Change Per Share is kr0.57 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.94 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr2.90 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biogaia.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.330.3%0.330.3%0.340.3%0.240.2%0.200.2%
Usd Book Value Change Per Share0.050.0%0.050.0%0.090.1%0.270.2%0.150.1%
Usd Dividend Per Share0.260.2%0.260.2%0.270.2%0.160.1%0.140.1%
Usd Total Gains Per Share0.320.3%0.320.3%0.360.3%0.430.4%0.290.2%
Usd Price Per Share9.19-9.19-7.59-30.22-27.56-
Price to Earnings Ratio27.97-27.97-22.59-167.84-160.56-
Price-to-Total Gains Ratio29.13-29.13-21.29-118.55-142.08-
Price to Book Ratio5.03-5.03-4.28-29.91-46.00-
Price-to-Total Gains Ratio29.13-29.13-21.29-118.55-142.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.70532
Number of shares93
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.260.16
Usd Book Value Change Per Share0.050.27
Usd Total Gains Per Share0.320.43
Gains per Quarter (93 shares)29.3340.32
Gains per Year (93 shares)117.33161.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1981910761101151
219639224121201312
329458341182302473
439278458243402634
549097575304503795
6588116692364603956
76861368094257041117
87841559264868041278
988217410435479051439
10980194116060710051600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.01.00.095.5%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%17.05.00.077.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.07.068.2%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.03.00.086.4%

Fundamentals of Biogaia

About BioGaia AB (publ)

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.

Fundamental data was last updated by Penke on 2024-04-19 16:51:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of BioGaia AB (publ).

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biogaia earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 28.2% means that kr0.28 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioGaia AB (publ):

  • The MRQ is 28.2%. The company is making a huge profit. +2
  • The TTM is 28.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.2%TTM28.2%0.0%
TTM28.2%YOY33.9%-5.7%
TTM28.2%5Y27.1%+1.1%
5Y27.1%10Y29.2%-2.1%
1.1.2. Return on Assets

Shows how efficient Biogaia is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • 15.7% Return on Assets means that Biogaia generated kr0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioGaia AB (publ):

  • The MRQ is 15.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 15.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.7%TTM15.7%0.0%
TTM15.7%YOY16.9%-1.2%
TTM15.7%5Y15.9%-0.2%
5Y15.9%10Y25.1%-9.2%
1.1.3. Return on Equity

Shows how efficient Biogaia is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • 18.0% Return on Equity means Biogaia generated kr0.18 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioGaia AB (publ):

  • The MRQ is 18.0%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.0%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ18.0%TTM18.0%0.0%
TTM18.0%YOY19.0%-1.0%
TTM18.0%5Y18.9%-0.9%
5Y18.9%10Y30.4%-11.5%

1.2. Operating Efficiency of BioGaia AB (publ).

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biogaia is operating .

  • Measures how much profit Biogaia makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 34.0% means the company generated kr0.34  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioGaia AB (publ):

  • The MRQ is 34.0%. The company is operating very efficient. +2
  • The TTM is 34.0%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ34.0%TTM34.0%0.0%
TTM34.0%YOY32.7%+1.3%
TTM34.0%5Y32.2%+1.8%
5Y32.2%10Y35.8%-3.6%
1.2.2. Operating Ratio

Measures how efficient Biogaia is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.66 means that the operating costs are kr0.66 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of BioGaia AB (publ):

  • The MRQ is 0.660. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.660. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.660TTM0.6600.000
TTM0.660YOY0.697-0.037
TTM0.6605Y0.679-0.019
5Y0.67910Y0.657+0.022

1.3. Liquidity of BioGaia AB (publ).

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biogaia is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 9.58 means the company has kr9.58 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of BioGaia AB (publ):

  • The MRQ is 9.576. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.576. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.576TTM9.5760.000
TTM9.576YOY10.894-1.318
TTM9.5765Y10.081-0.505
5Y10.08110Y7.257+2.824
1.3.2. Quick Ratio

Measures if Biogaia is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 6.96 means the company can pay off kr6.96 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioGaia AB (publ):

  • The MRQ is 6.963. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.963. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.963TTM6.9630.000
TTM6.963YOY8.155-1.192
TTM6.9635Y8.196-1.232
5Y8.19610Y6.098+2.097

1.4. Solvency of BioGaia AB (publ).

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biogaia assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biogaia to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.13 means that Biogaia assets are financed with 13.0% credit (debt) and the remaining percentage (100% - 13.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioGaia AB (publ):

  • The MRQ is 0.130. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.130. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.130TTM0.1300.000
TTM0.130YOY0.109+0.021
TTM0.1305Y0.136-0.006
5Y0.13610Y0.159-0.023
1.4.2. Debt to Equity Ratio

Measures if Biogaia is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 14.9% means that company has kr0.15 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioGaia AB (publ):

  • The MRQ is 0.149. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.149. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.149TTM0.1490.000
TTM0.149YOY0.122+0.027
TTM0.1495Y0.162-0.013
5Y0.16210Y0.193-0.031

2. Market Valuation of BioGaia AB (publ)

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Biogaia generates.

  • Above 15 is considered overpriced but always compare Biogaia to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 27.97 means the investor is paying kr27.97 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioGaia AB (publ):

  • The EOD is 32.587. Based on the earnings, the company is overpriced. -1
  • The MRQ is 27.971. Based on the earnings, the company is overpriced. -1
  • The TTM is 27.971. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD32.587MRQ27.971+4.616
MRQ27.971TTM27.9710.000
TTM27.971YOY22.590+5.382
TTM27.9715Y167.842-139.870
5Y167.84210Y160.556+7.285
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioGaia AB (publ):

  • The EOD is 31.559. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 27.089. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 27.089. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD31.559MRQ27.089+4.470
MRQ27.089TTM27.0890.000
TTM27.089YOY28.034-0.945
TTM27.0895Y188.318-161.229
5Y188.31810Y193.573-5.254
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biogaia is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of BioGaia AB (publ):

  • The EOD is 5.864. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.033. Based on the equity, the company is overpriced. -1
  • The TTM is 5.033. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.864MRQ5.033+0.831
MRQ5.033TTM5.0330.000
TTM5.033YOY4.279+0.755
TTM5.0335Y29.908-24.874
5Y29.90810Y46.003-16.095
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioGaia AB (publ) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5740.5740%0.941-39%2.977-81%1.685-66%
Book Value Per Share--20.10620.1060%19.532+3%16.149+25%10.261+96%
Current Ratio--9.5769.5760%10.894-12%10.081-5%7.257+32%
Debt To Asset Ratio--0.1300.1300%0.109+19%0.136-5%0.159-18%
Debt To Equity Ratio--0.1490.1490%0.122+22%0.162-8%0.193-23%
Dividend Per Share--2.9002.9000%2.984-3%1.798+61%1.534+89%
Eps--3.6183.6180%3.699-2%2.593+40%2.213+63%
Free Cash Flow Per Share--3.7363.7360%2.981+25%2.400+56%1.917+95%
Free Cash Flow To Equity Per Share--0.6820.6820%-0.124+118%2.716-75%1.451-53%
Gross Profit Margin--0.0060.0060%0.142-96%0.046-87%0.193-97%
Intrinsic Value_10Y_max--50.634--------
Intrinsic Value_10Y_min--25.570--------
Intrinsic Value_1Y_max--3.416--------
Intrinsic Value_1Y_min--2.101--------
Intrinsic Value_3Y_max--11.527--------
Intrinsic Value_3Y_min--6.750--------
Intrinsic Value_5Y_max--21.161--------
Intrinsic Value_5Y_min--11.842--------
Market Cap11469194100.000+11%10219409772.00010219409772.0000%8439091646.700+21%33297954793.740-69%29982493375.380-66%
Net Profit Margin--0.2820.2820%0.339-17%0.271+4%0.292-4%
Operating Margin--0.3400.3400%0.327+4%0.322+6%0.358-5%
Operating Ratio--0.6600.6600%0.697-5%0.679-3%0.657+1%
Pb Ratio5.864+14%5.0335.0330%4.279+18%29.908-83%46.003-89%
Pe Ratio32.587+14%27.97127.9710%22.590+24%167.842-83%160.556-83%
Price Per Share117.900+14%101.200101.2000%83.570+21%332.854-70%303.492-67%
Price To Free Cash Flow Ratio31.559+14%27.08927.0890%28.034-3%188.318-86%193.573-86%
Price To Total Gains Ratio33.941+14%29.13429.1340%21.290+37%118.549-75%142.081-79%
Quick Ratio--6.9636.9630%8.155-15%8.196-15%6.098+14%
Return On Assets--0.1570.1570%0.169-7%0.159-1%0.251-38%
Return On Equity--0.1800.1800%0.190-5%0.189-5%0.304-41%
Total Gains Per Share--3.4743.4740%3.925-12%4.775-27%3.219+8%
Usd Book Value--184355235.200184355235.2000%179095554.400+3%147717943.680+25%93177697.880+98%
Usd Book Value Change Per Share--0.0520.0520%0.085-39%0.270-81%0.153-66%
Usd Book Value Per Share--1.8261.8260%1.774+3%1.466+25%0.932+96%
Usd Dividend Per Share--0.2630.2630%0.271-3%0.163+61%0.139+89%
Usd Eps--0.3290.3290%0.336-2%0.235+40%0.201+63%
Usd Free Cash Flow--34254390.80034254390.8000%27333251.600+25%21933393.760+56%17299524.720+98%
Usd Free Cash Flow Per Share--0.3390.3390%0.271+25%0.218+56%0.174+95%
Usd Free Cash Flow To Equity Per Share--0.0620.0620%-0.011+118%0.247-75%0.132-53%
Usd Market Cap1041402824.280+11%927922407.298927922407.2980%766269521.520+21%3023454295.272-69%2722410398.485-66%
Usd Price Per Share10.705+14%9.1899.1890%7.588+21%30.223-70%27.557-67%
Usd Profit--33173961.60033173961.6000%33938588.400-2%23652946.000+40%19924343.880+66%
Usd Revenue--117722744.800117722744.8000%100239386.400+17%85370160.000+38%68623116.960+72%
Usd Total Gains Per Share--0.3150.3150%0.356-12%0.434-27%0.292+8%
 EOD+4 -4MRQTTM+0 -0YOY+16 -205Y+21 -1510Y+22 -14

3.2. Fundamental Score

Let's check the fundamental score of BioGaia AB (publ) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1532.587
Price to Book Ratio (EOD)Between0-15.864
Net Profit Margin (MRQ)Greater than00.282
Operating Margin (MRQ)Greater than00.340
Quick Ratio (MRQ)Greater than16.963
Current Ratio (MRQ)Greater than19.576
Debt to Asset Ratio (MRQ)Less than10.130
Debt to Equity Ratio (MRQ)Less than10.149
Return on Equity (MRQ)Greater than0.150.180
Return on Assets (MRQ)Greater than0.050.157
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of BioGaia AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.939
Ma 20Greater thanMa 50116.855
Ma 50Greater thanMa 100123.368
Ma 100Greater thanMa 200115.446
OpenGreater thanClose116.500
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets2,333,189
Total Liabilities302,845
Total Stockholder Equity2,030,342
 As reported
Total Liabilities 302,845
Total Stockholder Equity+ 2,030,342
Total Assets = 2,333,189

Assets

Total Assets2,333,189
Total Current Assets1,874,432
Long-term Assets458,757
Total Current Assets
Cash And Cash Equivalents 1,544,192
Net Receivables -181,204
Inventory 181,204
Other Current Assets 330,240
Total Current Assets  (as reported)1,874,432
Total Current Assets  (calculated)1,874,432
+/-0
Long-term Assets
Property Plant Equipment 213,328
Goodwill 165,174
Intangible Assets 46,230
Other Assets 0
Long-term Assets  (as reported)458,757
Long-term Assets  (calculated)424,732
+/- 34,025

Liabilities & Shareholders' Equity

Total Current Liabilities195,734
Long-term Liabilities107,111
Total Stockholder Equity2,030,342
Total Current Liabilities
Short-term Debt 8,800
Accounts payable 49,308
Other Current Liabilities 129,093
Total Current Liabilities  (as reported)195,734
Total Current Liabilities  (calculated)187,201
+/- 8,533
Long-term Liabilities
Long-term Liabilities Other 91,932
Long-term Liabilities  (as reported)107,111
Long-term Liabilities  (calculated)91,932
+/- 15,179
Total Stockholder Equity
Common Stock20,196
Retained Earnings 840,833
Accumulated Other Comprehensive Income 15,936
Other Stockholders Equity 1,153,377
Total Stockholder Equity (as reported)2,030,342
Total Stockholder Equity (calculated)2,030,342
+/-0
Other
Capital Stock20,196
Cash and Short Term Investments 1,544,192
Common Stock Shares Outstanding 100,982
Current Deferred Revenue8,533
Liabilities and Stockholders Equity 2,333,189
Net Debt -1,535,392
Net Invested Capital 2,030,342
Net Working Capital 1,678,698
Property Plant and Equipment Gross 379,071
Short Long Term Debt Total 8,800



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
161,633
135,902
108,508
87,153
90,763
110,773
154,306
179,814
227,822
279,832
517,022
383,419
415,608
473,178
488,978
576,112
659,973
665,900
1,913,282
2,128,054
2,213,966
2,333,189
2,333,1892,213,9662,128,0541,913,282665,900659,973576,112488,978473,178415,608383,419517,022279,832227,822179,814154,306110,77390,76387,153108,508135,902161,633
   > Total Current Assets 
129,126
102,761
72,088
62,592
67,352
80,945
111,922
154,133
207,374
255,392
467,812
323,116
332,761
365,061
385,340
454,337
494,415
452,438
1,689,577
1,752,077
1,797,481
1,874,432
1,874,4321,797,4811,752,0771,689,577452,438494,415454,337385,340365,061332,761323,116467,812255,392207,374154,133111,92280,94567,35262,59272,088102,761129,126
       Cash And Cash Equivalents 
120,566
92,906
62,173
48,349
39,719
42,977
58,127
100,327
146,903
171,534
374,974
234,271
210,666
226,882
243,069
305,856
284,962
213,831
1,467,883
1,484,680
1,488,366
1,544,192
1,544,1921,488,3661,484,6801,467,883213,831284,962305,856243,069226,882210,666234,271374,974171,534146,903100,32758,12742,97739,71948,34962,17392,906120,566
       Short-term Investments 
0
0
0
0
830
620
0
80
80
80
80
80
13
13
13
5,000
4,832
4,983
0
0
0
0
00004,9834,8325,000131313808080808006208300000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
72,050
98,592
89,688
98,558
105,251
154,819
156,316
143,196
-102,737
-142,838
-181,204
-181,204-142,838-102,737143,196156,316154,819105,25198,55889,68898,59272,05000000000000
       Inventory 
1,140
3,588
4,513
6,402
5,718
10,029
19,168
13,177
14,028
21,528
20,845
14,585
21,148
43,546
40,479
32,612
44,213
68,445
72,277
102,737
142,838
181,204
181,204142,838102,73772,27768,44544,21332,61240,47943,54621,14814,58520,84521,52814,02813,17719,16810,0295,7186,4024,5133,5881,140
       Other Current Assets 
7,420
6,267
5,402
7,841
21,085
27,319
34,627
40,549
46,363
62,250
71,913
74,180
100,934
94,620
101,779
110,869
160,408
165,179
6,221
267,397
309,115
330,240
330,240309,115267,3976,221165,179160,408110,869101,77994,620100,93474,18071,91362,25046,36340,54934,62727,31921,0857,8415,4026,2677,420
   > Long-term Assets 
32,507
33,141
36,420
24,561
23,411
29,828
42,384
25,681
20,448
24,440
49,210
60,303
82,847
108,117
103,638
121,775
165,558
213,462
223,705
375,977
416,485
458,757
458,757416,485375,977223,705213,462165,558121,775103,638108,11782,84760,30349,21024,44020,44825,68142,38429,82823,41124,56136,42033,14132,507
       Property Plant Equipment 
3,256
2,132
1,476
1,091
1,389
2,617
3,936
5,424
4,216
24,158
49,194
60,286
72,752
83,934
82,429
102,463
105,933
149,392
162,765
153,635
157,726
213,328
213,328157,726153,635162,765149,392105,933102,46382,42983,93472,75260,28649,19424,1584,2165,4243,9362,6171,3891,0911,4762,1323,256
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,300
5,300
5,300
149,227
171,517
165,174
165,174171,517149,2275,3005,3005,3000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
4,000
7,936
10,752
9,932
0
0
0
0
0
0
0000009,93210,7527,9364,000000000000000
       Intangible Assets 
24,987
27,753
28,096
15,076
11,416
8,199
5,050
2,285
1,173
0
0
0
6,075
16,225
0
0
45,850
52,558
50,322
48,086
46,075
46,230
46,23046,07548,08650,32252,55845,8500016,2256,0750001,1732,2855,0508,19911,41615,07628,09627,75324,987
       Long-term Assets Other 
4,264
3,256
6,848
8,394
6,248
5,047
12,298
4,511
4,498
18
16
17
33
35
37
5,041
45
-350
39
43
49
0
0494339-350455,0413735331716184,4984,51112,2985,0476,2488,3946,8483,2564,264
> Total Liabilities 
33,639
21,054
17,006
15,374
16,233
15,863
21,886
18,696
40,499
49,477
60,228
66,562
71,017
77,345
73,798
112,224
151,852
158,026
167,037
250,687
241,548
302,845
302,845241,548250,687167,037158,026151,852112,22473,79877,34571,01766,56260,22849,47740,49918,69621,88615,86316,23315,37417,00621,05433,639
   > Total Current Liabilities 
10,789
17,054
9,156
15,374
16,233
15,863
21,886
18,696
40,499
49,292
35,518
66,477
70,825
76,994
73,466
111,446
145,173
124,800
135,062
126,954
164,991
195,734
195,734164,991126,954135,062124,800145,173111,44673,46676,99470,82566,47735,51849,29240,49918,69621,88615,86316,23315,3749,15617,05410,789
       Short-term Debt 
0
7,850
0
2,984
0
0
0
664
1,029
0
0
0
0
0
0
0
0
8,900
8,900
10,400
20,088
8,800
8,80020,08810,4008,9008,900000000001,0296640002,98407,8500
       Accounts payable 
2,744
2,303
1,790
3,734
6,540
6,032
0
8,100
9,373
17,769
14,731
17,808
16,952
23,638
16,951
20,893
34,009
28,491
48,046
42,313
32,050
49,308
49,30832,05042,31348,04628,49134,00920,89316,95123,63816,95217,80814,73117,7699,3738,10006,0326,5403,7341,7902,3032,744
       Other Current Liabilities 
8,045
6,901
7,366
8,656
9,693
9,831
21,886
9,932
30,097
31,523
20,787
48,669
53,873
53,356
56,515
90,553
92,973
3,816
11,945
7,169
103,682
129,093
129,093103,6827,16911,9453,81692,97390,55356,51553,35653,87348,66920,78731,52330,0979,93221,8869,8319,6938,6567,3666,9018,045
   > Long-term Liabilities 
22,850
4,000
7,850
0
0
0
0
0
0
185
24,710
85
192
351
332
778
6,679
33,226
31,975
123,733
76,557
107,111
107,11176,557123,73331,97533,2266,6797783323511928524,7101850000007,8504,00022,850
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,254
20,700
10,400
0
0
0010,40020,70017,25400000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
85
192
351
332
778
6,679
21,826
11,312
113,920
71,644
0
071,644113,92011,31221,8266,6797783323511928500000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
6,075
16,225
0
0
45,850
0
0
0
0
0
0000045,8500016,2256,075000000000000
> Total Stockholder Equity
127,994
114,848
91,502
71,779
74,530
94,910
132,420
161,284
187,225
229,764
453,303
317,341
344,492
395,851
415,198
463,904
504,982
507,872
1,746,243
1,877,365
1,972,416
2,030,342
2,030,3421,972,4161,877,3651,746,243507,872504,982463,904415,198395,851344,492317,341453,303229,764187,225161,284132,42094,91074,53071,77991,502114,848127,994
   Common Stock
17,108
17,108
17,208
17,208
17,208
17,208
17,208
17,208
17,271
17,271
17,271
17,271
17,271
17,336
17,336
17,336
17,336
17,336
20,196
20,196
20,196
20,196
20,19620,19620,19620,19617,33617,33617,33617,33617,33617,27117,27117,27117,27117,27117,20817,20817,20817,20817,20817,20817,10817,108
   Retained Earnings 
178,338
114,358
137,654
-156,889
-154,169
-134,510
-120
65,428
44,071
128,348
429,393
294,852
321,361
356,414
374,872
423,013
464,278
466,666
578,584
703,188
772,730
840,833
840,833772,730703,188578,584466,666464,278423,013374,872356,414321,361294,852429,393128,34844,07165,428-120-134,510-154,169-156,889137,654114,358178,338
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,096
43,662
43,662
21,831
1,149,483
1,154,008
1,153,794
0
01,153,7941,154,0081,149,48321,83143,66243,66220,09600000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
-67,452
-16,618
-63,360
211,460
211,491
212,212
115,332
78,648
125,883
84,145
6,639
5,218
5,860
22,101
22,990
23,555
23,368
23,870
1,147,463
1,153,981
1,153,794
1,153,377
1,153,3771,153,7941,153,9811,147,46323,87023,36823,55522,99022,1015,8605,2186,63984,145125,88378,648115,332212,212211,491211,460-63,360-16,618-67,452



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,296,506
Cost of Revenue-346,316
Gross Profit950,190950,190
 
Operating Income (+$)
Gross Profit950,190
Operating Expense-509,281
Operating Income440,909440,909
 
Operating Expense (+$)
Research Development106,776
Selling General Administrative39,249
Selling And Marketing Expenses363,256
Operating Expense509,281509,281
 
Net Interest Income (+$)
Interest Income18,515
Interest Expense-809
Other Finance Cost-1,890
Net Interest Income15,816
 
Pretax Income (+$)
Operating Income440,909
Net Interest Income15,816
Other Non-Operating Income Expenses0
Income Before Tax (EBT)468,834412,984
EBIT - interestExpense = 440,100
468,834
366,161
Interest Expense809
Earnings Before Interest and Taxes (EBIT)440,909469,643
Earnings Before Interest and Taxes (EBITDA)466,190
 
After tax Income (+$)
Income Before Tax468,834
Tax Provision-95,671
Net Income From Continuing Ops437,421373,163
Net Income365,352
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses855,597
Total Other Income/Expenses Net27,925-15,816
 

Technical Analysis of Biogaia
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biogaia. The general trend of Biogaia is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biogaia's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioGaia AB (publ).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 120.60 < 123.80 < 135.60.

The bearish price targets are: 109.90 > 109.40 > 109.40.

Tweet this
BioGaia AB (publ) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioGaia AB (publ). The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioGaia AB (publ) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioGaia AB (publ). The current macd is -1.89392159.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biogaia price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biogaia. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biogaia price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BioGaia AB (publ) Daily Moving Average Convergence/Divergence (MACD) ChartBioGaia AB (publ) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioGaia AB (publ). The current adx is 22.09.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biogaia shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
BioGaia AB (publ) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioGaia AB (publ). The current sar is 119.79.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioGaia AB (publ) Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioGaia AB (publ). The current rsi is 46.94. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
BioGaia AB (publ) Daily Relative Strength Index (RSI) ChartBioGaia AB (publ) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioGaia AB (publ). The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biogaia price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BioGaia AB (publ) Daily Stochastic Oscillator ChartBioGaia AB (publ) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioGaia AB (publ). The current cci is 8.65800866.

BioGaia AB (publ) Daily Commodity Channel Index (CCI) ChartBioGaia AB (publ) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioGaia AB (publ). The current cmo is 0.82696666.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BioGaia AB (publ) Daily Chande Momentum Oscillator (CMO) ChartBioGaia AB (publ) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioGaia AB (publ). The current willr is -36.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biogaia is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioGaia AB (publ) Daily Williams %R ChartBioGaia AB (publ) Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BioGaia AB (publ).

BioGaia AB (publ) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioGaia AB (publ). The current atr is 2.91165544.

BioGaia AB (publ) Daily Average True Range (ATR) ChartBioGaia AB (publ) Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioGaia AB (publ). The current obv is 987,817.

BioGaia AB (publ) Daily On-Balance Volume (OBV) ChartBioGaia AB (publ) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioGaia AB (publ). The current mfi is 67.42.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
BioGaia AB (publ) Daily Money Flow Index (MFI) ChartBioGaia AB (publ) Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioGaia AB (publ).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

BioGaia AB (publ) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioGaia AB (publ) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.939
Ma 20Greater thanMa 50116.855
Ma 50Greater thanMa 100123.368
Ma 100Greater thanMa 200115.446
OpenGreater thanClose116.500
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biogaia with someone you think should read this too:
  • Are you bullish or bearish on Biogaia? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biogaia? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioGaia AB (publ)

I send you an email if I find something interesting about BioGaia AB (publ).


Comments

How you think about this?

Leave a comment

Stay informed about BioGaia AB (publ).

Receive notifications about BioGaia AB (publ) in your mailbox!